New Hernia Care Products Improve Patient Outcomes

New mesh and fixation technologies offer improved treatment options for minimally invasive hernia procedures.

The three new hernia care products, developed by Covidien (Dublin, Ireland) are designed to address clinical needs in laparoscopic inguinal, ventral, and umbilical hernia repair, including reduced recurrence, pain, and risk of infection, as well as shorter procedure time and lower cost.


The new hernia care products, which have been approved by the US Food and Drug Administration (FDA), are (1) ProGrip Laparoscopic Self-Fixating Mesh, which provides tack-free fixation over the entire anatomy, including below the inguinal ligament where traditional tacks cannot be placed. Progrip seamlessly combines mesh and fixation into one device to increase the security of laparoscopic inguinal hernia repair, while eliminating the pain and reducing costs associated with a traditional mesh anchored with standard tacks. (2) Parietex Composite Ventral Patch, designed for optimal abdominal wall conformability in umbilical and small ventral hernia repair, with a unique design that allows for easy deployment and peripheral fixation. The Parietex composite ventral patch features a macro-porous textile supporting consistent tissue integration and a clinically proven collagen film technology to minimize visceral attachment. (3) AbsorbaTack 30X Absorbable Fixation Device - designed with patient comfort in mind, the device provides strong, temporary mesh fixation while leaving no foreign material in the body over time. The new AbsorbaTack 30X fixation device also features an enhanced drive mechanism and new shaft for optimal tack deployment in challenging situations.

“We believe product innovations such as ProGrip laparoscopic self-fixating mesh enables less invasive hernia procedures that will result in better patient outcomes,” said Rob Claypoole, vice president and general manager of Hernia Care at Covidien. “Even though hernia repair is one of the most frequently performed surgical procedures, there are opportunities to further reduce postoperative pain, improve recurrence rates and facilitate less invasive techniques. As a leader in the market, we are looking forward to the future of hernia care and believe that patients will benefit from these three new products.”

Related Links:
Covidien